Professor Rob Whitbourn established and is Director of Cardiac Catheterization Laboratories and Director Ambulatory Services at St Vincent’s Hospital Melbourne an performs diagnostic and interventional cardiac procedures at Albury Wodonga Private Hospital in partnership with Dr Kugan Nadarasa.

He is a Fellow of the Cardiac Society of Australia and New Zealand and an internationally recognised leader in Interventional Cardiology, Heart Disease and novel devices. His research career spans over 20 years, including 2 years as Interventional Cardiology and Research Fellow at Stanford University Medical Centre in the US. 

He has been principal investigator on multiple research projects and numerous first-in-man cardiovascular technologies ranging novel coronary bifurcated , drug eluting and bioabsorbable stents, to more recently, pioneering renal sympathetic denervation for resistant systemic hypertension.